logo

Operating Model Simplification And Evoqua Integration Will Drive Customer Agility

AN
Consensus Narrative from 17 Analysts
Published
20 Aug 24
Updated
07 May 25
Share
AnalystConsensusTarget's Fair Value
US$138.66
11.4% undervalued intrinsic discount
07 May
US$122.85
Loading
1Y
-14.1%
7D
-1.1%

Author's Valuation

US$138.7

11.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Key Takeaways

  • Organizational restructuring and acquisitions aim to enhance revenue growth, agility, and customer focus, bolstering margin expansion.
  • Strategic supply chain and pricing measures maintain stability amid external pressures, supporting margins and potential order rebounds.
  • Economic challenges, including tariffs and FX fluctuations, could pressure Xylem's margins and revenue growth while integration and demand risks further complicate forecasts.

Catalysts

About Xylem
    Engages in the design, manufacture, and servicing of engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide.
What are the underlying business or industry changes driving this perspective?
  • Xylem’s efforts in simplifying their operating model and reorienting their organizational structure are expected to enhance customer focus and agility, contributing to potential margin expansion and improved revenue growth.
  • Integration of recently acquired companies like Evoqua and systematic capital deployment, including a focus on M&A, are anticipated to drive revenue synergies and augment future earnings.
  • Xylem has implemented pricing actions and has strategic supply chain measures in place to offset tariff impacts, maintaining stability in revenue and margins despite external pressures.
  • The company has a robust backlog and bid activity, expected to support revenue growth particularly in sectors like Measurement & Control Solutions, marking a potential rebound in orders and margin performance in the second half of the year.
  • Organizational restructuring and simplification efforts, such as the implementation of 80/20 methodologies, are predicted to improve productivity and drive sustained EBITDA margin expansion across Xylem’s segments.

Xylem Earnings and Revenue Growth

Xylem Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Xylem's revenue will grow by 4.6% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 10.5% today to 13.3% in 3 years time.
  • Analysts expect earnings to reach $1.3 billion (and earnings per share of $5.4) by about May 2028, up from $906.0 million today.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 32.2x on those 2028 earnings, down from 32.4x today. This future PE is greater than the current PE for the US Machinery industry at 21.6x.
  • Analysts expect the number of shares outstanding to grow by 0.37% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.32%, as per the Simply Wall St company report.

Xylem Future Earnings Per Share Growth

Xylem Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Higher tariffs, especially from China, could increase production costs and squeeze margins if Xylem cannot fully offset these with pricing and supply chain strategies. This could impact net margins and earnings.
  • Economic challenges, particularly in China, may lead to decreased order volumes, which can affect revenue growth in Xylem's Water Infrastructure segment.
  • If Xylem's price increases to offset tariff impacts result in decreased demand, this could soften revenue growth. The company is uncertain about the full extent of demand loss, which poses a risk to revenue and earnings forecasts.
  • Execution risks in transforming organizational structures and integrating acquisitions like Evoqua could lead to short-term disruptions in operations or unforeseen expenses, impacting net margins or earnings.
  • FX fluctuations, particularly if adverse, could pose a risk to revenue forecasts since guidance assumes no material headwinds from currency shifts.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of $138.659 for Xylem based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $174.0, and the most bearish reporting a price target of just $114.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $9.8 billion, earnings will come to $1.3 billion, and it would be trading on a PE ratio of 32.2x, assuming you use a discount rate of 7.3%.
  • Given the current share price of $120.45, the analyst price target of $138.66 is 13.1% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives